Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG2 Injection for Fatigue After Palliative Abdominal Surgery
NCT02077621Phase 2Withdrawn
- Sponsor
- PhytoHealth Corporation
- Start
- Feb 2014
- Primary completion
- Dec 2020
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer-related fatigue (CRF) comparing PG2 with Placebo (2 arms). Primary endpoint: Change from baseline fatigue status at Day 84. Planned start Feb 2014; status: withdrawn.
02
Drugs
astragalus polysaccharides
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT02077621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02077621.